Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 12Unknown 5Terminated 3Recruiting 2Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Erectile Dysfunction 3Prostatic Neoplasms 2Penile Neoplasms 1

Interventions

Cyclophosphamide 391Carboplatin 344Gemcitabine 332pembrolizumab 331Cisplatin 328Paclitaxel 298Radiotherapy 297Docetaxel 287Bevacizumab 253Rituximab 234Capecitabine 224Nivolumab 222Dexamethasone 206Fluorouracil 190fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 134Cetuximab 130fludarabine phosphate 129Bortezomib 129Lenalidomide 126Filgrastim 120Erlotinib Hydrochloride 120Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Sildenafil Citrate × Clear all
NCT00955929 2021-11-10

Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy

Memorial Sloan Kettering Cancer Center

Phase NA Terminated
76 enrolled 9 charts
Genitourinary

Erectile Dysfunction, Penile Neoplasms

NCT01996852 2019-05-10

Improving Erectile Function and Quality of Life After Prostate Cancer Treatment

Case Comprehensive Cancer Center

Phase NA Terminated
34 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

NCT00544076 2019-01-02

ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancer

City of Hope Medical Center

Phase 3 Terminated
110 enrolled 9 charts
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡